Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The importance of estrogen for bone protection in experimental hyperthyroidism in human osteoblasts.

Olímpio RMC, Moretto FCF, De Sibio MT, de Oliveira M, Mathias LS, Gonçalves BM, Deprá IC, Tilli HP, Rodrigues BM, Saraiva PP, Maria DA, Nogueira CR.

Life Sci. 2019 Aug 15;231:116556. doi: 10.1016/j.lfs.2019.116556. Epub 2019 Jun 10.

PMID:
31194990
2.

Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.

Wang QP, Yang L, Li XP, Xie H, Liao EY, Wang M, Luo XH.

Bone. 2012 Sep;51(3):515-23. doi: 10.1016/j.bone.2012.05.011. Epub 2012 May 23.

PMID:
22634178
3.

Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.

Fioramonti M, Santini D, Iuliani M, Ribelli G, Manca P, Papapietro N, Spiezia F, Vincenzi B, Denaro V, Russo A, Tonini G, Pantano F.

Oncotarget. 2017 Mar 21;8(12):20113-20121. doi: 10.18632/oncotarget.15390.

4.

[Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts].

Ma XN, Ge BF, Chen KM, Zhou J, Shi WG, Xie YF, Guo XY, Lv X, Cheng K, Gao YH.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Aug;35(4):432-8. doi: 10.3881/j.issn.1000-503X.2013.04.014. Chinese.

5.

[Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].

Liu CG, Luo QX, Ling TY, Mo YY, Cheng ZL, Huang SG, Mo H.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Dec;33(12):1658-64. Chinese.

PMID:
24517065
6.

The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.

Peng S, Liu XS, Huang S, Li Z, Pan H, Zhen W, Luk KD, Guo XE, Lu WW.

Bone. 2011 Dec;49(6):1290-8. doi: 10.1016/j.bone.2011.08.031. Epub 2011 Sep 9.

PMID:
21925296
7.

Omentin-1 exerts bone-sparing effect in ovariectomized mice.

Xie H, Xie PL, Luo XH, Wu XP, Zhou HD, Tang SY, Liao EY.

Osteoporos Int. 2012 Apr;23(4):1425-36. doi: 10.1007/s00198-011-1697-8. Epub 2011 Jul 14.

PMID:
21755404
8.

Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.

Xu F, Dong Y, Huang X, Chen P, Guo F, Chen A, Huang S.

Mol Med Rep. 2016 Sep;14(3):2289-96. doi: 10.3892/mmr.2016.5515. Epub 2016 Jul 13.

PMID:
27430581
9.

Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.

Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N.

Bone. 2008 Mar;42(3):535-46. doi: 10.1016/j.bone.2007.11.008. Epub 2007 Nov 29.

PMID:
18166509
10.

Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.

Viereck V, Gründker C, Friess SC, Frosch KH, Raddatz D, Schoppet M, Nisslein T, Emons G, Hofbauer LC.

J Bone Miner Res. 2005 Nov;20(11):2036-43. Epub 2005 Jul 18.

11.

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.

Lee DW, Kwon JY, Kim HK, Lee HJ, Kim ES, Kim HJ, Kim HJ, Lee HB.

Int J Med Sci. 2018 May 14;15(7):723-729. doi: 10.7150/ijms.22713. eCollection 2018.

13.

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.

Michael H, Härkönen PL, Väänänen HK, Hentunen TA.

J Bone Miner Res. 2005 Dec;20(12):2224-32. Epub 2005 Aug 1.

14.

The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Enjuanes A, Ruiz-Gaspà S, Peris P, Ozalla D, Álvarez L, Combalia A, Martínez de Osaba MJ, Monegal A, Pares A, Guañabens N.

Endocrine. 2010 Feb;37(1):180-6. doi: 10.1007/s12020-009-9285-9. Epub 2009 Nov 24.

PMID:
20963568
15.

IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice.

Singh K, Piprode V, Mhaske ST, Barhanpurkar-Naik A, Wani MR.

J Immunol. 2018 Jan 15;200(2):595-606. doi: 10.4049/jimmunol.1601528. Epub 2017 Dec 4.

16.

Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.

El Kholy K, Freire M, Chen T, Van Dyke TE.

Front Immunol. 2018 Jun 12;9:1300. doi: 10.3389/fimmu.2018.01300. eCollection 2018.

17.

PTH differentially regulates expression of RANKL and OPG.

Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA.

J Bone Miner Res. 2004 Feb;19(2):235-44. Epub 2003 Dec 16.

18.

Prolactin decreases the expression ratio of receptor activator of nuclear factor kappaB ligand/osteoprotegerin in human fetal osteoblast cells.

Seriwatanachai D, Charoenphandhu N, Suthiphongchai T, Krishnamra N.

Cell Biol Int. 2008 Sep;32(9):1126-35. doi: 10.1016/j.cellbi.2008.04.026. Epub 2008 May 9.

PMID:
18556224
19.

Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.

Kitamura K, Takahira K, Inari M, Satoh Y, Hayakawa K, Tabuchi Y, Ogai K, Nishiuchi T, Kondo T, Mikuni-Takagaki Y, Chen W, Hattori A, Suzuki N.

Comp Biochem Physiol A Mol Integr Physiol. 2013 Sep;166(1):74-80. doi: 10.1016/j.cbpa.2013.04.023. Epub 2013 Apr 28.

PMID:
23632157
20.

Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.

J Cell Physiol. 2005 Jun;203(3):573-82.

PMID:
15573398

Supplemental Content

Support Center